USPTO 2015–2025 USPTO PatentsView US Corporation

Pivot Bio, Inc.

USPTO PatentsView assignee record — 17 granted patents across 15 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

17
Total patents granted
15
CPC technology areas
30.6
Avg claims per patent
+650%
5-year filing velocity

Portfolio overview

Pivot Bio, Inc. has been granted 17 US utility patents between 2018 and 2025, placing Pivot Bio, Inc. at rank #17,096 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 30.6 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Pivot Bio, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 50.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 15 grants, compared with 2 in the 2015–2019 window — a +650% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Pivot Bio, Inc.'s 30.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Pivot Bio, Inc. against peers pursuing similar technology classes.

How does Pivot compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Pivot holds 17 patents — placing it at rank #17,096 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2018–2025

0123456 2018201920202021202320242025 5
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Pivot Bio, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 5.9%
2019 1 5.9%
2020 1 5.9%
2021 2 11.8%
2023 4 23.5%
2024 3 17.6%
2025 5 29.4%

Which technologies does Pivot Bio, Inc. patent most?

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#17,096

Across all tracked assignees

Innovation Score

50.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Pivot Bio, Inc. hold?
Pivot Bio, Inc. holds 17 US granted patents filed between 2018 and 2025, spanning 15 technology areas.
What is Pivot Bio, Inc.'s Innovation Score?
Pivot Bio, Inc. has an Innovation Score of 50.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Pivot Bio, Inc. focus on?
Pivot Bio, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 11 patents. The company has filed patents in 15 CPC subclasses total.
Is Pivot Bio, Inc.'s patent filing rate increasing or decreasing?
Pivot Bio, Inc.'s recent filing velocity is +650% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Pivot Bio, Inc.'s patents?
Pivot Bio, Inc.'s patents average 30.6 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Pivot Bio, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope